Minimal Residual Disease in Head and Neck Cancer

By Gath H.J.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 1, 1999-01 ,pp. : 109-126

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

By Kasimir-Bauer S.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 123-132

Springer Publishing Company

Access to resources Recommend Favorite

CTL-defined Cancer Vaccines: Perspectives for Active Immunotherapeutic Interventions in Minimal Residual Disease

By Jäger E.   Jäger D.   Knuth A.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 1, 1999-01 ,pp. : 143-150

Springer Publishing Company

Access to resources Recommend Favorite

Diagnosis of Minimal Residual Disease in Bone Marrow and Blood in Cancer Patients: Methods and Clinical Implications

By Kvalheim G.  

Acta Oncologica, Vol. 37, Iss. 5, 1998-10 ,pp. : 455-462

Informa Healthcare

Access to resources Recommend Favorite

Single-dose Intraperitoneal Radioimmunotherapy with the Murine Monoclonal Antibody I-131 MOv18: Clinical Results in Patients with Minimal Residual Disease of Ovarian Cancer

By Crippa F.   Bolis G.   Seregni E.   Gavoni N.   Scarfone G.   Ferraris C.   Buraggi G.L.   Bombardieri E.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 686-690

Elsevier

Access to resources Recommend Favorite